Thank you everyone who attended our live webinar in association with SCIEX. Below are some responses to…
Exploratory biomarker testing: to qualify or validate the assay? The latest scientific and regulatory considerations for biomarker validation
Webinar live date: Thursday 5 September 2019 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. This webinar will discuss considerations for biomarker assay design and technology selection, including singleplex and multiplex ligand binding and immunometric assays, as well as optimization of pre-analytical factors and core assay performance expectations.
Bioanalytical project management – a critical function adapted to the study type(s) of your drug development program
Webinar live date: 10 September 2019 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. Join us for a discussion on proactive, effective and efficient bioanalytical project management.
Webinar available to view on demand. Learn about the most advanced methods for quantitating and characterizing therapeutic oligonucleotides.
Webinar available to view on demand. Register for our exclusive panel discussion focusing on the new ICH M10 guideline on bioanalytical method validation.
Webinar available to view on demand. Join us for a discussion on how bioanalytical data is used in early-phase clinical trials to advance drug development.
Case Study: Cytokine Receptor α/β/γ Measured by Serial Immunoaffinity with Capture Microflow LC–MS/MS
Webinar available to view on demand. Learn how using serial immunoaffinity (IA) enrichment and targeted MS offers the possibility to measure multiple protein targets with great sensitivity from a single sample.
Panel discussion available to view on demand. In this free panel discussion, our experts will provide insights into their own research using flow cytometry including the challenges they have had to overcome, key trends they have seen and their future outlook on the development of this field.
Webinar available to view on demand. Register for our exclusive Coffee Chat focusing on patient-centric sampling. This informal discussion centers on this new type of workflow that benefits the patient, enabling the collection of previously difficult data.
Available to view on demand. Receptor occupancy measurement by flow cytometry is a rapid, quantifiable and an important addition to PK and PD data in the biopharmaceutical development process.